 |
|
Survival rates exceed national averages for UCSF heart, liver and lung transplant programs
March 03, 2008One-year survival rates for patients receiving heart, liver and lung transplants at UCSF Medical Center exceed national averages at statistically significant levels, according to new data compiled by the Scientific Registry of Transplant Recipients (SRTR).
Released on January 11, the report measures performance and characteristics of each transplant program at all facilities in the United States, including waiting list outcomes, post-transplant survival rates, and organ recovery and transplantation rates. Reported statistics can be found on the SRTR website (http://www.ustransplant.org).
"The registry collects data from the nation's transplant programs and uses an algorithm they created to standardize calculations across facilities, looking at such information as how sick patients are in each program and then assigning an expected survival rate," explained John P. Roberts, MD, chief of the UCSF Medical Center Transplant Service.
According to the report, the one-year survival rate for the UCSF Heart Transplant Program was 100 percent, compared to an expected survival rate of 87 percent. The UCSF Liver Transplant Program produced a one-year survival rate of 92 percent compared to an expected 88 percent, and the Lung Transplant Program generated a one-year survival rate of 90 percent compared to an expected 80 percent. The expected survival rates reflect the health condition of each program's transplant patients.
UCSF is recognized for tackling the most complex transplant surgeries, including multiple organ transplants, and is the only hospital among the U.S. News & World Report top 18 hospitals with these three programs that exceeds the national averages for expected survival rates at significant levels.
UCSF transplant teams include a full range of patient care and support personnel, and all are committed to achieving better-than-expected survival rates, according to Roberts and also emphasized by Teresa De Marco, MD, medical director of the UCSF Heart Transplant Program.
Many audiences, such as patients and families looking to select a transplant program, use the SRTR data. Transplant surgeons use it to explain a patient's prospects for recovery, as do administrators addressing quality control for transplant programs, insurance companies and payers, and federal regulatory bodies charged with protecting patients.
Transplants are the most advanced treatment for patients with severe, end-stage disease with no other effective, available medical or surgical treatments, according to clinicians.
The Heart Transplant Program at UCSF began in 1989 and is expected to soon perform its 500th procedure. The program focuses on pulmonary hypertension and right ventricular failure, combined heart-kidney transplant, transplant for Chagas disease, transplant for congenital heart disease, transplant for HIV, and research on the genomics of heart failure and allograft loss (rejection of donor organ).
Since it began in 1988, the Liver Transplant Program has performed more than 2,100 liver transplants for adults and children. The program is designated as a Center of Excellence by the U.S. Department of Health and Human Services and performs more liver transplants than any other hospital in Northern California. Program specialists are currently conducting research in the areas of living donor transplantation, liver cancer, clinical therapeutics in liver transplantation, transplantation in HIV-infected patients, hepatitis C antiviral therapy, and recurrent viral disease.
The UCSF Lung Transplant Program has performed more than 250 transplants since the program began in 1991, and it is a specialized center of excellence for treating cystic fibrosis and pulmonary hypertension. The program also focuses on ECMO (extracorporeal membrane oxygenation) as a bridge to transplant for acute respiratory failure, the role of transplant in malignancy (bronchoalveolar carcinoma), and transplant for HIV patients. Current research includes the genomics of transplant rejection, acute lung injury and fungal infections.
Information about all of UCSF's transplant programs can be found at: http://www.ucsfhealth.org/adult/medical_services/ organ_transplants/.
UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.
The University of California, San Francisco
According to the report, the one-year survival rate for the UCSF Heart Transplant Program was 100 percent, compared to an expected survival rate of 87 percent. The UCSF Liver Transplant Program produced a one-year survival rate of 92 percent compared to an expected 88 percent, and the Lung Transplant Program generated a one-year survival rate of 90 percent compared to an expected 80 percent. The expected survival rates reflect the health condition of each program's transplant patients.
UCSF is recognized for tackling the most complex transplant surgeries, including multiple organ transplants, and is the only hospital among the U.S. News & World Report top 18 hospitals with these three programs that exceeds the national averages for expected survival rates at significant levels.
UCSF transplant teams include a full range of patient care and support personnel, and all are committed to achieving better-than-expected survival rates, according to Roberts and also emphasized by Teresa De Marco, MD, medical director of the UCSF Heart Transplant Program.
Many audiences, such as patients and families looking to select a transplant program, use the SRTR data. Transplant surgeons use it to explain a patient's prospects for recovery, as do administrators addressing quality control for transplant programs, insurance companies and payers, and federal regulatory bodies charged with protecting patients.
Transplants are the most advanced treatment for patients with severe, end-stage disease with no other effective, available medical or surgical treatments, according to clinicians.
The Heart Transplant Program at UCSF began in 1989 and is expected to soon perform its 500th procedure. The program focuses on pulmonary hypertension and right ventricular failure, combined heart-kidney transplant, transplant for Chagas disease, transplant for congenital heart disease, transplant for HIV, and research on the genomics of heart failure and allograft loss (rejection of donor organ).
Since it began in 1988, the Liver Transplant Program has performed more than 2,100 liver transplants for adults and children. The program is designated as a Center of Excellence by the U.S. Department of Health and Human Services and performs more liver transplants than any other hospital in Northern California. Program specialists are currently conducting research in the areas of living donor transplantation, liver cancer, clinical therapeutics in liver transplantation, transplantation in HIV-infected patients, hepatitis C antiviral therapy, and recurrent viral disease.
The UCSF Lung Transplant Program has performed more than 250 transplants since the program began in 1991, and it is a specialized center of excellence for treating cystic fibrosis and pulmonary hypertension. The program also focuses on ECMO (extracorporeal membrane oxygenation) as a bridge to transplant for acute respiratory failure, the role of transplant in malignancy (bronchoalveolar carcinoma), and transplant for HIV patients. Current research includes the genomics of transplant rejection, acute lung injury and fungal infections.
Information about all of UCSF's transplant programs can be found at: http://www.ucsfhealth.org/adult/medical_services/ organ_transplants/.
UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.
The University of California, San Francisco
Transplant News and Current Transplant Events RSSMaking 'good' fat from muscle and vice versa
A surprise discovery -- that calorie-burning brown fat can be produced experimentally from muscle precursor cells in mice -- raises the prospect of new ways to fight obesity and overweight, say scientists from Dana-Farber Cancer Institute.
Children's national co-leads nationwide study of landmark sickle cell treatment
Children's National Medical Center immunologist and blood and marrow transplant physician Naynesh Kamani, MD, will serve as the study co-chair for a new national clinical trial of unrelated donor marrow and umbilical cord blood transplants for severe sickle cell disease.
Trapping white blood cells proves novel strategy against chronic viral infections
Seeing disease-fighting white blood cells vanish from the blood usually signals a weakened immune system. But preventing white blood cells' circulation by trapping them in the lymph nodes can help mice get rid of a chronic viral infection, researchers at Yerkes National Primate Research Center and the Emory Vaccine Center have found.
Trapping white blood cells proves novel strategy against chronic viral infections
Seeing disease-fighting white blood cells vanish from the blood usually signals a weakened immune system. But preventing white blood cells' circulation by trapping them in the lymph nodes can help mice get rid of a chronic viral infection, researchers at Yerkes National Primate Research Center and the Emory Vaccine Center have found.
Protein key to control, growth of blood cells
New research sheds light on the biological events by which stem cells in the bone marrow develop into the broad variety of cells that circulate in the blood. The findings may help improve the success of bone marrow transplants and may lead to better treatments for life-threatening blood diseases.
Newly discovered proteins in seminal fluid may affect odds of producing offspring
Seminal fluid contains protein factors that, when transferred from a male to a female at mating, affect reproductive success. This is true of many different animals, from crickets to primates.
NewYork-Presbyterian/Columbia leads research into robotic surgery for kidney cancer
Clinical research at NewYork-Presbyterian Hospital/Columbia University Medical Center is helping bring the advantages of robotic surgery, including reduced pain and quicker recovery, to kidney cancer patients.
CMV infections affect more than just patients with compromised immune systems, researchers find
An infection due to a virus called cytomegalovirus (CMV), which most commonly affects people with compromised immune systems, can also affect hospital intensive-care patients who have no immune-system problems, University of Washington researchers have found.
'Statins' linked to improved survival in kidney transplant recipients
For patients receiving kidney transplants, treatment with cholesterol-lowering "statin" drugs may lead to longer survival, reports a study in the November 2008 Journal of the American Society of Nephrology (JASN).
Older liver donors not associated with negative outcomes in transplant recipients with hepatitis C
Receiving a liver from a donor older than age 60 does not appear to be associated with transplant failure, death or recurrent disease in the next five years among transplant patients with the hepatitis C virus.
More Transplant News Articles
 | Change of Heart: A Novel by Jodi Picoult The acclaimed #1 New York Times bestselling author presents a spellbinding tale of a mother's tragic loss and one man's last chance at gaining salvation.Can we save ourselves, or do we rely on others to do it? Is what we believe always the truth? One moment June Nealon was happily looking forward to years full of laughter and adventure with her family, and the next, she was staring into a future... |
 | When Crickets Cry by Charles Martin A man with a painful past. A child with a doubtful future. And a shared journey toward healing for both their hearts. It begins on the shaded town square in a sleepy Southern town. A spirited seven-year-old has a brisk business at her lemonade stand. Her latest customer, a bearded stranger, drains his cup and heads to his car, his mind on a boat he's restoring at a nearby lake. But the... |
 | Driving Sideways: A Novel by Jess Riley Leigh Fielding wants a life. Seriously. Having spent the past five years on dialysis, she has one simple wish: to make it to her thirtieth birthday. Now, thanks to the generosity of the late Larry Resnick and his transplanted kidney, it looks like her wish may come true.With her newfound vitality (and Larry’s kidney) in tow, Leigh hits the road for an excursion that will carry her from... |
 | Sick Girl by Amy Silverstein “[With] humor and radiant courage . . . Silverstein delivers a searing insight into the battle to stay alive.”—Ted Koppel“Spectacular.”—Mehmet Oz, MD, cardiothoracic surgeon and coauthor of You: The Owner’s ManualAt just twenty-four, Amy Silverstein was your typical type-A law student: smart, driven, and highly competitive. With a budding romance and a... |
 | Every Second Counts: The Race to Transplant the First Human Heart by Donald McRae Many remember the proudly beaming face of South African surgeon Christiaan Barnard after he performed the first human heart transplant. But he was not alone in his quest. In truth it was a fourway race, a fierce struggle fraught with passionate rivalry. Three other surgeons were giants in the field, and by early December 1967 all were poised to make medical history. Each had spent years... |
 | Sick Girl Speaks!: Lessons and Ponderings Along the Road to Acceptance by Tiffany Christensen Surprise! I’m still not dead! Okay, sure, I was born with an incurable genetic disease and, yes, I have faced terminal illness two times but … here I am! And I’m ready to speak! I’ve now been navigating the Western medical maze for over three decades. Along the way, I’ve had to learn some pretty painful lessons about how to advocate for myself and what happens if I don’t. I also know how scary... |
 | Twice Dead: Organ Transplants and the Reinvention of Death (Public Anthropology) by Margaret Lock Tales about organ transplants appear in mythology and folk stories, and surface in documents from medieval times, but only during the past twenty years has medical knowledge and technology been sufficiently advanced for surgeons to perform thousands of transplants each year. In the majority of cases individuals diagnosed as "brain dead" are the source of the organs without which transplants could... |
 | The Grateful Heart: Diary of a Heart Transplant by Candace C. Moose In August 2001 the author received immunizations in anticipation of travel to Africa to help children suffering from HIV/AIDS. Soon after the shots, she feel prey to an extraordinarily rare and generally fatal disease. She received a heart transplant 7 weeks later, and fought bravely and successfully to overcome many obstacles in her recovery. She received caring help from many hands as she... |
 | Core Curriculum for Transplant Nurses (Critical Care Nursing ( Clochesy)) by ITNS Endorsed by the International Transplant Nurses Association, this book provides a guide to safe and effective care for solid organ transplant recipients. It includes coverage of the unique requirements of each organ transplanted, with separate chapters for heart, lung, kidney, liver, small intestine, and pancreas/islet cell transplantation. Other chapters cover important topics that affect all... |
 | Confirming Justice (Justice Series #2) by Diane/David Munson Followup to bestselling Facing Justice. In Confirming Justice an Indian tribe demands justice from a Federal judge in a bribery case that could reach the White House. The son of the Secretary of Interior is charged with taking money from the tribe to influence his father. When the star witness suddenly disappears the FBI is called in setting in motion events which could topple the... |
| © 2008 BrightSurf.com |